|
|
 |
|
BIIB: Biogen Idec Inc - Stock News |
Enter Ticker:
|
|
| Nov 18, 2009 |
Genentech and Biogen Idec Receive a Complete Response from the FDA for Rituxan for Chronic Lymphocytic Leukemia |
| Nov 13, 2009 |
Wider Loss for Alnylam |
| Nov 12, 2009 |
Biogen Idec to Present at the Annual Credit Suisse Healthcare Conference |
| Nov 11, 2009 |
BiomedReports: News and FDA Updates for Alexion (Nasdaq:ALXN), Biogen (NASDAQ:BIIB), Elan (NYSE:ELN) |
| Nov 11, 2009 |
Complimentary Sector & Company Analysis on ABAT, EXEL, LBTYA, BEBE,INTU and BIIB From TheFortuneFinancial.com |
| Nov 10, 2009 |
CORRECTING and REPLACING Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference |
| Nov 10, 2009 |
Biogen Idec to Present at the Lazard Capital Markets 6th Annual Healthcare Conference |
| Nov 10, 2009 |
BiomedReports: News and FDA Updates for Alnylam (Nasdaq:ALNY), Antares (NYSE:AIS), Biogen (NASDAQ:BIIB) |
| Nov 09, 2009 |
Biogen Idec to Present at the 2009 Annual Credit Suisse Healthcare Conference |
| Nov 09, 2009 |
Biogen Idec Down 6.3% Since SmarTrend's Sell Recommendation |
| Nov 06, 2009 |
Acorda Therapeutics (ACOR) |
| Nov 04, 2009 |
MMR Information Systems Engages Global Research Services as Advisorto Accelerate Time to Market for Anti-CD20 Monoclonal Antibodies |
| Nov 04, 2009 |
Trading Outlook for MannKind Corp. Issued by InvestorSoup.com |
| Nov 03, 2009 |
Facet Biotech Reports Third Quarter 2009 Financial Results |
| Nov 02, 2009 |
Biogen Idec (BIIB) NewsBite - BIIB Upgraded By Jefferies |
| |
| ZACKS COMMENTARY FOR BIIB |
| Nov 20, 2009 | Zacks Blog: Biogen's Rituxan Label Expansion Delayed | | Nov 12, 2009 | Zacks Blog: Wider Loss for Alnylam | | Nov 10, 2009 | Zacks Blog: Zacks Industry Outlook Highlights: Alcon, Novartis, Gilead Sciences, Biogen Idec and Acorda Therapeutics | | Nov 02, 2009 | Zacks Blog: Medicines Co. Misses & Cuts | | Oct 28, 2009 | Zacks Blog: FDA Approval for Glaxo Drug | | Oct 27, 2009 | Zacks Blog: BioMarin Purchases Huxley | | Oct 26, 2009 | Zacks Equity Research: Report for BIIB | | Oct 21, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec, Elan, UnitedHealth Group Inc., Forest Laboratories, Inc. and Cypress Biosciences | | Oct 20, 2009 | Zacks Blog: Biogen Reports Higher Earnings | | Oct 20, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Biogen Idec Inc., Facet Biotech Corporation, Trubion Pharmaceuticals, Bristol-Myers Squibb and Acorda Therapeutics | | Oct 19, 2009 | Zacks Blog: Biogen Extends Hostile Bid | | Oct 14, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: American International Group, Morgan Stanley, Elan Corporation, Biogen Idec and Johnson & Johnson |
|
|
Sponsored Links 
0.53